Panview Capital Ltd purchased a new position in shares of FormFactor, Inc. (NASDAQ:FORM – Free Report) during the 2nd quarter, HoldingsChannel reports. The firm purchased 228,647 shares of the semiconductor company’s stock, valued at approximately $36,568,000. FormFactor accounts for about 6.4% of Panview Capital Ltd’s holdings, making the stock its 8th largest holding.
Other hedge funds and other institutional investors have also modified their holdings of the company. Keating Financial Advisory Services Inc. acquired a new stake in shares of FormFactor in the 2nd quarter valued at $25,000. Persistent Asset Partners Ltd bought a new stake in FormFactor in the second quarter worth $43,000. Los Angeles Capital Management LLC acquired a new position in FormFactor during the fourth quarter worth $25,000. Allworth Financial LP acquired a new position in FormFactor during the second quarter worth $72,000. Finally, USA Financial Formulas bought a new position in FormFactor during the first quarter valued at about $46,000. Institutional investors own 98.76% of the company’s stock.
Wall Street Analyst Weigh In
FORM has been the subject of several recent analyst reports. Wall Street Zen downgraded FormFactor from a “strong-buy” rating to a “buy” rating in a research note on Sunday, August 9th. Evercore set a $150.00 price objective on FormFactor in a research note on Thursday, July 30th. Zacks Research raised shares of FormFactor from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 18th. Stifel Nicolaus set a $135.00 price objective on shares of FormFactor in a research note on Thursday, April 30th. Finally, Northland Securities set a $118.00 target price on shares of FormFactor in a research note on Thursday, April 30th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $127.45.
FormFactor Price Performance
NASDAQ FORM opened at $114.16 on Monday. The stock has a 50-day simple moving average of $122.39 and a 200 day simple moving average of $116.48. FormFactor, Inc. has a twelve month low of $27.81 and a twelve month high of $160.27. The stock has a market capitalization of $8.90 billion, a PE ratio of 78.19 and a beta of 1.25. The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.34 and a current ratio of 4.08.
FormFactor (NASDAQ:FORM – Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $0.82 EPS for the quarter, topping the consensus estimate of $0.61 by $0.21. FormFactor had a return on equity of 13.44% and a net margin of 12.80%.The company had revenue of $258.24 million for the quarter, compared to the consensus estimate of $240.00 million. During the same period in the previous year, the business posted $0.27 EPS. The company’s revenue for the quarter was up 31.9% on a year-over-year basis. FormFactor has set its Q3 2026 guidance at 0.770-0.950 EPS. Research analysts anticipate that FormFactor, Inc. will post 2.7 EPS for the current year.
Insider Activity
In other news, Director Dennis Thomas St sold 2,800 shares of the company’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $151.49, for a total transaction of $424,172.00. Following the completion of the transaction, the director owned 29,073 shares of the company’s stock, valued at approximately $4,404,268.77. This represents a 8.78% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Sheri Rhodes sold 6,328 shares of the stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $125.40, for a total transaction of $793,531.20. Following the completion of the sale, the director owned 5,375 shares of the company’s stock, valued at approximately $674,025. The trade was a 54.07% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 37,020 shares of company stock valued at $4,756,017. Insiders own 0.79% of the company’s stock.
Key Headlines Impacting FormFactor
Here are the key news stories impacting FormFactor this week:
- Positive Sentiment: Zacks increased its Q3 2026 EPS estimate to $0.78 from $0.48 and its FY2026 forecast to $2.68 from $1.99. Estimates for FY2027 rose to $3.11 from $2.19, while FY2028 increased to $3.39 from $2.47. These revisions signal stronger expected demand and profitability for FormFactor’s semiconductor testing business.
- Positive Sentiment: Quarterly estimates were also raised materially: Q4 2026 EPS increased to $0.70 from $0.53, Q1 2027 to $0.70 from $0.47, Q2 2027 to $0.75 from $0.58, and Q3 2027 to $0.85 from $0.56. Q1 and Q2 2028 estimates were lifted to $0.80 and $0.82, respectively.
- Neutral Sentiment: The upgrades are especially significant because the current full-year consensus estimate is $2.70 per share, close to Zacks’ revised FY2026 forecast. Investors may therefore view the revisions as supportive of longer-term growth but may wait for the company’s results and guidance to confirm the outlook.
- Negative Sentiment: FormFactor shares have decreased despite the favorable analyst revisions. The stock’s elevated valuation—approximately 78 times earnings—may be limiting enthusiasm, as investors could be taking profits or demanding stronger near-term results before assigning additional upside.
FormFactor Company Profile
FormFactor, Inc (NASDAQ:FORM) is a leading provider of advanced test and measurement solutions for the semiconductor industry. The company specializes in the design, development and manufacture of high-performance wafer-level and package-level test interfaces used in wafer sort, characterization, reliability and failure analysis applications. By leveraging precision microelectromechanical systems (MEMS) and photolithographic processes, FormFactor delivers probe cards, analytical probes and test sockets that enable device makers to validate next-generation integrated circuits across logic, memory, RF, analog and power applications.
FormFactor’s product portfolio includes custom probe cards for wafer probers, TEM-based analytical probes for material and device characterization, and socket solutions for burn-in and final test of packaged devices.
Recommended Stories
- Five stocks we like better than FormFactor
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding FORM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for FormFactor, Inc. (NASDAQ:FORM – Free Report).
Receive News & Ratings for FormFactor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FormFactor and related companies with MarketBeat.com's FREE daily email newsletter.
